22.01.2013 • NewsCollaborationcooperationDow Corning

Dow Corning, Crystal Solar Announce Collaboration in Solar Applications

Dow Corning, a global leader in silicones, silicon-based technology and innovation, and Crystal Solar, a solar energy venture company focusing on Direct Gas to Wafer technology, today announced their intention to develop a business relationship for the successful supply of high-performance, silicon-based materials for photovoltaic (PV) cells and modules.

The two companies also intend to assess options for developing high performance building integrated photovoltaic (BIPV) solutions for building and construction, focusing on both commercial and residential applications.

Dow Corning can provide access to high-quality trichlorosilane, specialized silicon-based materials, and supply chain consultancy to support a breakthrough manufacturing approach developed by Crystal Solar to produce monocrystalline ultra-thin silicon epi-wafers. Crystal Solar's innovative Epitaxial technology allows for high efficiency solar panels at lower costs with advanced functionality to competing approaches.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.